Entering text into the input field will update the search result below

Ionis teams up with Astrazeneca to develop and commercialize eplontersen

two people meeting in bubble

We Are/DigitalVision via Getty Images

  • Ionis Pharmaceuticals (NASDAQ:IONS) collaborates with AstraZeneca (NASDAQ:AZN) to develop and commercialize eplontersen, Ionis' investigational antisense medicine for the treatment of transthyretin amyloidosis (ATTR), a progressive and fatal disease.
  • Under the terms of the agreement, Ionis

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.